Publication:
Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain

dc.contributor.authorFernandez de Larrea-Baz, Nerea
dc.contributor.authorMichel, Angelika
dc.contributor.authorRomero, Beatriz
dc.contributor.authorPerez-Gomez, Beatriz
dc.contributor.authorMoreno, Victor
dc.contributor.authorMartin, Vicente
dc.contributor.authorDierssen-Sotos, Trinidad
dc.contributor.authorJimenez-Moleon, Jose J.
dc.contributor.authorCastilla, Jesus
dc.contributor.authorTardon, Adonina
dc.contributor.authorRuiz, Irune
dc.contributor.authorPeiro, Rosana
dc.contributor.authorTejada, Antonio
dc.contributor.authorChirlaque, Maria D.
dc.contributor.authorButt, Julia A.
dc.contributor.authorOlmedo-Requena, Rocio
dc.contributor.authorGomez-Acebo, Ines
dc.contributor.authorLinares, Pedro
dc.contributor.authorBoldo, Elena
dc.contributor.authorCastells, Antoni
dc.contributor.authorPawlita, Michael
dc.contributor.authorCastano-Vinyals, Gemma
dc.contributor.authorKogevinas, Manolis
dc.contributor.authorde Sanjose, Silvia
dc.contributor.authorPollan, Marina
dc.contributor.authordel Campo, Rosa
dc.contributor.authorWaterboer, Tim
dc.contributor.authorAragones, Nuria
dc.contributor.authoraffiliation[Fernandez de Larrea-Baz, Nerea] Inst Salud Carlos III, Area Natl Ctr Epidemiol, Environm & Canc Epidemiol Area, Madrid, Spain
dc.contributor.authoraffiliation[Perez-Gomez, Beatriz] Inst Salud Carlos III, Area Natl Ctr Epidemiol, Environm & Canc Epidemiol Area, Madrid, Spain
dc.contributor.authoraffiliation[Aragones, Nuria] Inst Salud Carlos III, Area Natl Ctr Epidemiol, Environm & Canc Epidemiol Area, Madrid, Spain
dc.contributor.authoraffiliation[Fernandez de Larrea-Baz, Nerea] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Dierssen-Sotos, Trinidad] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Jimenez-Moleon, Jose J.] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Castilla, Jesus] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Tardon, Adonina] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Peiro, Rosana] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Chirlaque, Maria D.] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Olmedo-Requena, Rocio] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Gomez-Acebo, Ines] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Boldo, Elena] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Castano-Vinyals, Gemma] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Kogevinas, Manolis] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[de Sanjose, Silvia] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Pollan, Marina] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Aragones, Nuria] CIBERESP, CIBER Epidemiol & Publ Hlth, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain
dc.contributor.authoraffiliation[Michel, Angelika] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany
dc.contributor.authoraffiliation[Butt, Julia A.] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany
dc.contributor.authoraffiliation[Pawlita, Michael] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany
dc.contributor.authoraffiliation[Waterboer, Tim] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect Infect Inflammat, Heidelberg, Germany
dc.contributor.authoraffiliation[Perez-Gomez, Beatriz] Ramon & Cajal Univ Hosp IRYCIS, Dept Microbiol, Madrid, Spain
dc.contributor.authoraffiliation[del Campo, Rosa] Ramon & Cajal Univ Hosp IRYCIS, Dept Microbiol, Madrid, Spain
dc.contributor.authoraffiliation[Perez-Gomez, Beatriz] IIS Puerta Hierro, Puerta Hierro Hlth Res Inst, Canc Epidemiol Res Grp Oncol & Hematol Area, Madrid, Spain
dc.contributor.authoraffiliation[Boldo, Elena] IIS Puerta Hierro, Puerta Hierro Hlth Res Inst, Canc Epidemiol Res Grp Oncol & Hematol Area, Madrid, Spain
dc.contributor.authoraffiliation[Pollan, Marina] IIS Puerta Hierro, Puerta Hierro Hlth Res Inst, Canc Epidemiol Res Grp Oncol & Hematol Area, Madrid, Spain
dc.contributor.authoraffiliation[Moreno, Victor] Hosp Llobregat, Catalan Inst Oncol, Canc Prevent & Control Program, Barcelona, Spain
dc.contributor.authoraffiliation[Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona, Spain
dc.contributor.authoraffiliation[Moreno, Victor] Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Colorectal Canc Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Martin, Vicente] Univ Leon, Res Grp Gene Environm & Hlth Interact, Leon, Spain
dc.contributor.authoraffiliation[Martin, Vicente] Univ Leon, Fac Hlth Sci, Dept Biomed Sci, Area Prevent Med & Publ Hlth, Leon, Spain
dc.contributor.authoraffiliation[Dierssen-Sotos, Trinidad] Univ Cantabria IDIVAL, Sch Med, Div Epidemiol & Computat Biol, Santander, Spain
dc.contributor.authoraffiliation[Jimenez-Moleon, Jose J.] Inst Invest Biosanitaria Granada, Granada Hlth Res Inst ibs GRANADA, Granada, Spain
dc.contributor.authoraffiliation[Olmedo-Requena, Rocio] Inst Invest Biosanitaria Granada, Granada Hlth Res Inst ibs GRANADA, Granada, Spain
dc.contributor.authoraffiliation[Jimenez-Moleon, Jose J.] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain
dc.contributor.authoraffiliation[Olmedo-Requena, Rocio] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain
dc.contributor.authoraffiliation[Castilla, Jesus] Inst Salud Publ Navarra, IdiSNA Navarra Inst Hlth Res, Pamplona, Spain
dc.contributor.authoraffiliation[Tardon, Adonina] Univ Oviedo, Oncol Inst, Dept Med, Mol Epidemiol Canc Unit, Oviedo, Spain
dc.contributor.authoraffiliation[Ruiz, Irune] Donostia Univ Hosp, Dept Pathol, Donostia San Sebastian, Spain
dc.contributor.authoraffiliation[Peiro, Rosana] Fdn Promot Hlth & Biomed Res Valencia Reg FISABIO, Fdn La Fomento Invest Sanitaria & Biomed Comunita, Valencia, Spain
dc.contributor.authoraffiliation[Tejada, Antonio] Huelva Univ, Hosp Complex, Dept Gen Surg, Coloproctol Unit, Huelva, Spain
dc.contributor.authoraffiliation[Chirlaque, Maria D.] IMIB Arrixaca, Reg Hlth Council, Dept Epidemiol, Murcia, Spain
dc.contributor.authoraffiliation[Chirlaque, Maria D.] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain
dc.contributor.authoraffiliation[Linares, Pedro] Univ Leon, Dept Gastroenterol & Hepatol Complejo Asis, Leon, Spain
dc.contributor.authoraffiliation[Castells, Antoni] Hosp Clin Barcelona, Gastroenterol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Castells, Antoni] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
dc.contributor.authoraffiliation[Castells, Antoni] CIBER Enfermed Hepat & Digestivas CIBEREHD, CIBER Liver & Digest Dis, Madrid, Spain
dc.contributor.authoraffiliation[Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Barcelona, Spain
dc.contributor.authoraffiliation[Castano-Vinyals, Gemma] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain
dc.contributor.authoraffiliation[Kogevinas, Manolis] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain
dc.contributor.authoraffiliation[Castano-Vinyals, Gemma] Hosp Mar, Med Res Inst IMIM, Barcelona, Spain
dc.contributor.authoraffiliation[Kogevinas, Manolis] Hosp Mar, Med Res Inst IMIM, Barcelona, Spain
dc.contributor.authoraffiliation[Castano-Vinyals, Gemma] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
dc.contributor.authoraffiliation[Kogevinas, Manolis] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
dc.contributor.authoraffiliation[de Sanjose, Silvia] Hosp Llobregat, Catalan Inst Oncol IDIBELL, Canc Epidemiol & Res Program, Barcelona, Spain
dc.contributor.authoraffiliation[del Campo, Rosa] Red Espanola Invest Patol Infecciosa, Spanish Network Res Infect Dis, Seville, Spain
dc.contributor.funder"Accion Transversal del Cancer"
dc.contributor.funderConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP)
dc.contributor.funderInstituto de Salud Carlos III grants
dc.contributor.funderFEDER funds-a way to build Europe
dc.contributor.funderFundacion Marques de Valdecilla
dc.contributor.funderCatalan Government DURSI
dc.contributor.funderJunta de Castilla y Leon
dc.contributor.funderConsejeria de Salud of the Junta de Andalucia
dc.contributor.funderRegional Government of the Basque Country
dc.contributor.funderConselleria de Sanitat of the Generalitat Valenciana
dc.date.accessioned2023-02-12T02:22:39Z
dc.date.available2023-02-12T02:22:39Z
dc.date.issued2017-05-29
dc.description.abstractBackground: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain.Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to >= 4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI).Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cag delta showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women.Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.
dc.identifier.doi10.3389/fmicb.2017.00888
dc.identifier.essn1664-302X
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fmicb.2017.00888/pdf
dc.identifier.urihttp://hdl.handle.net/10668/19223
dc.identifier.wosID402240600001
dc.journal.titleFrontiers in microbiology
dc.journal.titleabbreviationFront. microbiol.
dc.language.isoen
dc.organizationHospital Universitario Juan Ramón Jiménez
dc.organizationHospital Infanta Elena
dc.publisherFrontiers media sa
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectHelicobacter pylori
dc.subjectmultiplex serology
dc.subjectcolorectal neoplasm
dc.subjectchronic infection
dc.subjectbacterial infections
dc.subjectnon-infectious diseases
dc.subjectGastric-cancer
dc.subjectColon neoplasia
dc.subjectInfection
dc.subjectAssociation
dc.subjectMetaanalysis
dc.subjectCarcinoma
dc.titleHelicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number8
dc.wostypeArticle
dspace.entity.typePublication

Files